Simvastatin
Simvastatin is a well-established, inactive lactone HMG-CoA reductase inhibitor that is enzymatically opened into its active beta-hydroxy acid form post-absorption. It inhibits endogenous hepatic cholesterol synthesis, lowering total plasma cholesterol, LDL-C, and very-low-density lipoproteins (VLDL). Beyond its primary lipid-lowering pathways, it enhances endothelial nitric oxide synthase (eNOS) expression, boosting overall blood vessel dilation and preserving systemic tissue perfusion.
Cholesterol Management
LDL Reduction
Lipid Profile Optimization
Cholesterol Management
LDL Reduction
Lipid Profile Optimization
High Purity & Efficacy
USP / BP / EP / IP Grade Compliance
Stringent Quality Control & Batch Consistency
Pharmaceutical Formulations
Oral Solid Dosage (Tablets & Capsules)
Sterile Formulations / Injectables (where applicable)
Custom API Compounding
